Skip to main content
Fig. 2 | BMC Endocrine Disorders

Fig. 2

From: Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves’ disease

Fig. 2

Altered expression profile of receptors of BAFF on peripheral blood B lymphocytes in GD. a: Elevated BR3 expression on peripheral blood B lymphocytes in GD patients. Mean MFI of BR3 on peripheral B lymphocytes in GD patients was 4.52 ± 2.06, higher than that in HC (3.00 ± 0.87), P = 0.0015; BR3 expression in HT patients was not increased; b: Trend of decreased TACI expression on peripheral B lymphocytes in GD patients. Mean MFI of TACI on peripheral B lymphocytes in GD patients was 7.96 ± 4.06, lower than that in HC (9.10 ± 3.37) without significance, P = 0.1285. TACI expression in HT was not decreased. MFI: mean fluorescence intensity. Bars: mean MFI. ns: not significant; **: vs. HC, P < 0.01

Back to article page